Verma AK - Search Results

1

Tissue-resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge.

Odle A, Kar M, Verma AK, Sariol A, Meyerholz DK, Suthar MS, Wong LR, Perlman S. Odle A, et al. Among authors: verma ak. JCI Insight. 2024 Dec 6;9(23):e184074. doi: 10.1172/jci.insight.184074. JCI Insight. 2024. PMID: 39405115 Free PMC article.

2

SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways.

Verma AK, Zheng J, Meyerholz DK, Perlman S. Verma AK, et al. JCI Insight. 2022 Dec 22;7(24):e160277. doi: 10.1172/jci.insight.160277. JCI Insight. 2022. PMID: 36378534 Free PMC article.

3

A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.

Shi J, Zheng J, Zhang X, Tai W, Compas R, Deno J, Jachym N, Verma AK, Wang G, Guan X, Odle AE, Wan Y, Li F, Perlman S, Qiao L, Du L. Shi J, et al. Among authors: verma ak. JCI Insight. 2024 Mar 8;9(5):e155789. doi: 10.1172/jci.insight.155789. JCI Insight. 2024. PMID: 38456504 Free PMC article.

4

Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.

Wang G, Verma AK, Guan X, Bu F, Odle AE, Li F, Liu B, Perlman S, Du L. Wang G, et al. Among authors: verma ak. J Virol. 2024 Sep 17;98(9):e0037624. doi: 10.1128/jvi.00376-24. Epub 2024 Aug 27. J Virol. 2024. PMID: 39189731 Free article.

5

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice.

Zheng J, Wong LR, Li K, Verma AK, Ortiz ME, Wohlford-Lenane C, Leidinger MR, Knudson CM, Meyerholz DK, McCray PB Jr, Perlman S. Zheng J, et al. Among authors: verma ak. Nature. 2021 Jan;589(7843):603-607. doi: 10.1038/s41586-020-2943-z. Epub 2020 Nov 9. Nature. 2021. PMID: 33166988 Free PMC article.

6

Lipid nanoparticle-mRNA: another step in the fight against COVID-19.

Verma AK, Perlman S. Verma AK, et al. Cell Res. 2022 May;32(5):421-422. doi: 10.1038/s41422-022-00647-5. Cell Res. 2022. PMID: 35314770 Free PMC article. No abstract available.

7

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge.

Guan X, Verma AK, Wang G, Shi J, Perlman S, Du L. Guan X, et al. Among authors: verma ak. iScience. 2023 Sep 27;26(10):108033. doi: 10.1016/j.isci.2023.108033. eCollection 2023 Oct 20. iScience. 2023. PMID: 37822493 Free PMC article.

8

Adaptation of SARS-CoV-2 to ACE2_H353K mice reveals new spike residues that drive mouse infection.

Li K, Verma A, Li P, Ortiz ME, Hawkins GM, Schnicker NJ, Szachowicz PJ, Pezzulo AA, Wohlford-Lenane CL, Kicmal T, Meyerholz DK, Gallagher T, Perlman S, McCray PB Jr. Li K, et al. J Virol. 2024 Jan 23;98(1):e0151023. doi: 10.1128/jvi.01510-23. Epub 2024 Jan 3. J Virol. 2024. PMID: 38168680 Free PMC article.

9

Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.

Tan TJC, Verma AK, Odle A, Lei R, Meyerholz DK, Matreyek KA, Perlman S, Wong LR, Wu NC. Tan TJC, et al. Among authors: verma ak. Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2317222121. doi: 10.1073/pnas.2317222121. Epub 2024 Apr 1. Proc Natl Acad Sci U S A. 2024. PMID: 38557175 Free PMC article.

10

A predominately pulmonary activation of complement in a mouse model of severe COVID-19.

Szachowicz PJ, Wohlford-Lenane C, Heinen CJ, Ghimire S, Xue B, Boly TJ, Verma A, MašinoviĆ L, Bermick JR, Perlman S, Meyerholz DK, Pezzulo AA, Zhang Y, Smith RJH, McCray PB Jr. Szachowicz PJ, et al. bioRxiv [Preprint]. 2024 Jun 3:2024.05.31.596892. doi: 10.1101/2024.05.31.596892. bioRxiv. 2024. PMID: 38895461 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,331 results

Search Page

Filters